US Patent 10471142 Combination therapy using immunoglobulin and C1-Inhibitor
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+169 characters)
Article
Patent abstract
Methods are disclosed for treating cerebral ischemia using a combination of C1-INH and immunoglobulin, such as human plasma derived immunoglobulin (IVIG).
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Mark Mattson0
Milan Basta0
Xinzhi Chen0
Edits on 22 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 18 Jan, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 30 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10471142 Combination therapy using immunoglobulin and C1-Inhibitor
Infobox
Is a
Patent jurisdiction
Patent number
10471142
Date of patent
November 12, 2019
Patent application number
14346478
Date Filed
September 21, 2012
Patent primary examiner
Find more entities like US Patent 10471142 Combination therapy using immunoglobulin and C1-Inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
